Using Rezūm therapy for treating benign prostate enlargement in Canadian men
Official title: Canadian Cohort of Convective Thermal Therapy Using Rezūm System in Benign Prostatic Hyperplasia (BPH).
Run by Can-Am HIFU Inc. · NCT05201131 · Data updated 2026-11-12
This study is testing how well Rezūm therapy works for Canadian men with benign prostate enlargement and how satisfied they are with the treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Men only |
| Enrollment | 50 (estimated) |
| Sponsor | Can-Am HIFU Inc. Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | October 7, 2019 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2029 |
| Registry record updated | August 19, 2026 |
| Trial ID | NCT05201131 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are male patients aged 18 and older with a primary diagnosis of benign prostatic hyperplasia who are deemed suitable for Rezūm therapy.
✕Probably not a fit
Patients with health conditions that make them unsuitable for the study or those unable to comply with the study protocol may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to document the clinical outcomes of the Rezūm therapy for patients diagnosed with benign prostatic hyperplasia (BPH) within a Canadian cohort. Male subjects aged 18 and older who are candidates for Rezūm therapy will be monitored for their responses to the treatment. The study will involve collecting data through questionnaires to assess the effectiveness and patient satisfaction with the therapy. The findings will contribute to understanding the therapy's impact on BPH management in Canada.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the effectiveness of Rezūm therapy for managing benign prostatic hyperplasia, potentially improving patient care.
How similar studies have gone: While this study focuses on a specific Canadian cohort, similar approaches using Rezūm therapy have shown promise in other populations, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male subjects of ≥ 18 years of age. * Primary diagnosis of Benign Prostate Hypertrophy (BPH). * Candidate for Rezūm therapy as per clinical decision of Investigator. * Willing and able to accurately complete the required questionnaires. * Willing and able to provide signed and dated informed consent Exclusion Criteria: * Characteristics indicating a poor compliance with study protocol requirements. * Disease or other health condition that is not suitable for this study. * Unable or unwilling to provide signed informed consent.
Where it's running
-
Dean Elterman
Toronto, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Dean Elterman — University Health Network, Toronto
- Study coordinator: Iris Chan
- Email: iris.chan2@uhn.ca
- Phone: 416-603-5800
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Urine, perineal, and stool microbiota in children and adolescents
We will test whether the bacteria in voided urine, around the genitals, and in stool differ between children with overactive bladder or daytime wetting and healthy children of the same age and gender.
-
21-day comprehensive spa care for kidney and urinary conditions
This program will try a 21-day spa treatment with mineral water baths, drinking cures, exercise and diet for adults 40–70 who have chronic kidney or urinary problems to see if it improves symptoms and kidney health.
-
Hospital admissions for blood in the urine
This international observational project will look at how hospitals manage adults admitted with blood in the urine to see which approaches lead to shorter stays and better outcomes.
-
Using AI language models to help diagnose and recommend treatments for urologic conditions
This project will test whether three AI language models (ChatGPT, Gemini, DeepSeek) can accurately recognize urologic diseases and suggest diagnoses and treatments from archived hospital records of adult patients.
-
Virtual reality to reduce pain and anxiety during outpatient urology procedures
This trial will try a virtual reality headset (REALICA®) to reduce pain and anxiety for adults having outpatient urology procedures such as circumcision, prostate biopsy, or flexible cystoscopy.
-
Using vorolanib for treating advanced kidney cancer
This study is testing if the drug vorolanib can help people with advanced kidney cancer live longer when used as a second treatment option.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.